About Celerion
Celerion is a company based in Lincoln (United States) founded in 2010 was acquired by Thomas H Lee Partners in April 2026. The company has 940 employees as of December 31, 2022. Celerion offers products and services including Bioanalytical Sciences, ClinQuick, and Celexus. Celerion operates in a competitive market with competitors including Altasciences, Ask Gene Pharma, Open Orphan, iCardiac Technologies and AWAKN, among others.
- Headquarter Lincoln, United States
- Employees 940 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Celerion, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Thomas H Lee Partners
& 2 more
-
Employee Count
940
as on Dec 31, 2022
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Celerion
Celerion offers a comprehensive portfolio of products and services, including Bioanalytical Sciences, ClinQuick, and Celexus.
Delivers analysis of molecules for drug development phases
Platform for efficient clinical trial management
System for data handling in research studies
People of Celerion
Unlock access to complete
Data Analysis and Operations Team
34 people
Senior Team
21 people
Leadership Team
20 people
Clinical Team
18 people
Sales and Marketing
17 people
Software Development Team
14 people
Finance and Accounting
13 people
Product Management Team
11 people
Unlock access to complete
Funding Insights of Celerion
Detailed funding history for Celerion
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Celerion
Celerion has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Thomas H Lee Partners, WindRose Health Investors and H.I.G. Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US healthcare investments are managed by private equity firm.
|
Locked | Locked | Locked | |
|
Private equity investments are directed toward traditional industries.
|
Locked | Locked | Locked | |
|
Private equity capital is invested in small and mid-sized businesses.
|
Locked | Locked | Locked |
Investor details for Celerion
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Celerion
Investment portfolio details for Celerion
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Celerion
Detailed financials for Celerion
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Celerion Comparisons
Peer comparison for Celerion
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Celerion
Celerion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Altasciences, Ask Gene Pharma, Open Orphan, iCardiac Technologies and AWAKN, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Early phase clinical research services are provided in North America.
|
|
| Locked | Locked | Locked |
Biosimilars and biosuperiors are developed and commercialized in biotechnology.
|
|
| Locked | Locked | Locked |
Provider of testing vaccines & antivirals and CRO pharmaceutical services
|
|
| Locked | Locked | Locked |
Cardiac safety testing and respiratory laboratory services are provided.
|
|
| Locked | Locked | Locked |
CRO focused on early stage clinical trial research
|
Detailed competitors of Celerion
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Celerion
Complete news archive for Celerion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Celerion
Celerion was founded in 2010.
Celerion is headquartered in Lincoln, United States. It is registered at Lincoln, Nebraska, United States.
As of Dec 31, 2022, the latest employee count at Celerion is 940.
Celerion provides early clinical research services for pharmaceutical and biotechnology companies in the United States and internationally. The company focuses on delivering applied translational medicine to support early drug development decisions. Its services include global clinical research (Phase I and II, and NDA-enabling clinical pharmacology study conduct); clinical pharmacology sciences (modeling and simulation, study design and protocol development, clinical data sciences, biostatistics, pharmacokineticspharmacodynamics (PKPD), and medical writing and reporting); global bioanalytical services (discovery to late stage services with capabilities in small and large drug, and metabolite and biomarker molecules); and drug development services (program and project management, regulatory services, and drug development consultancy). The company also specializes in providing medical writing (protocols and reports), clinical data sciences, biostatistics, and PKPD analysis, as well as small and large molecule bioanalytical assays through clinical drug development. It serves its clients through its global network of owned facilities in Lincoln, Nebraska; Phoenix and Tempe, Arizona; West Conshohocken, Pennsylvania; Montreal, Canada; Belfast, Northern Ireland; and Zurich, Switzerland. The company was founded in 2010 and is based in Lincoln, Nebraska. It also has operations in Richmond, Virginia; Montreal, Canada; and South Korea. The company was formed when Bain CapitalVentures and SV Life Sciences acquired MDS Pharma Services Early Stage Business. In 2014 they divested a majority stake in the company to MTS Partners.
Celerion's top competitors include Ask Gene Pharma, HMR London and Altasciences.
Celerion offers Bioanalytical Sciences, ClinQuick, and Celexus.
Celerion has 3 investors. Key investors include Thomas H Lee Partners, WindRose Health Investors, and H.I.G. Capital.